AUTHOR=Chuong Michael D. , Kaiser Adeel , Khan Fazal , Parikh Parag , Ben-Josef Edgar , Crane Christopher , Brunner Thomas , Okumura Toshiyuki , Schreuder Niek , Bentzen Søren M. , Gutierrez Alonso , Mendez Romero Alejandra , Yoon Sang Min , Sharma Navesh , Kim Tae Hyun , Kishi Kazushi , Moeslein Fred , Hoffe Sarah , Schefter Tracey , Hanish Steven , Scorsetti Marta , Apisarnthanarax Smith TITLE=Consensus Report From the Miami Liver Proton Therapy Conference JOURNAL=Frontiers in Oncology VOLUME=9 YEAR=2019 URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2019.00457 DOI=10.3389/fonc.2019.00457 ISSN=2234-943X ABSTRACT=

An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.